Khiron Life Sciences Corp. (KHRNF)
KHRNF Stock Price Chart
Explore Khiron Life Sciences Corp. interactive price chart. Choose custom timeframes to analyze KHRNF price movements and trends.
KHRNF Company Profile
Discover essential business fundamentals and corporate details for Khiron Life Sciences Corp. (KHRNF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jan 2021
Employees
310.00
Website
https://khiron.caCEO
Alvaro Francisco Torres
Description
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
KHRNF Financial Timeline
Browse a chronological timeline of Khiron Life Sciences Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Nov 2025
Earnings released on 1 Aug 2025
Earnings released on 26 Aug 2024
Earnings released on 28 May 2024
Earnings released on 28 Feb 2024
Earnings released on 20 Oct 2023
Earnings released on 1 Sept 2023
Earnings released on 20 Jun 2023
Earnings released on 19 Apr 2023
Earnings released on 30 Nov 2022
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $2.47M , missing expectations by -28.73%.
Earnings released on 26 Aug 2022
EPS came in at -$0.01 surpassing the estimated -$0.02 by +35.61%, while revenue for the quarter reached $3.47M , missing expectations by -9.65%.
Earnings released on 30 May 2022
EPS came in at -$0.02 falling short of the estimated -$0.02 by -0.63%, while revenue for the quarter reached $3.71M , beating expectations by +5.61%.
Earnings released on 2 May 2022
EPS came in at -$0.09 falling short of the estimated $0.01 by -1.18K%, while revenue for the quarter reached $2.85M , missing expectations by -9.83%.
Earnings released on 22 Nov 2021
EPS came in at -$0.01 , while revenue for the quarter reached $2.78M .
Earnings released on 23 Aug 2021
EPS came in at -$0.03 , while revenue for the quarter reached $2.26M .
Earnings released on 27 May 2021
EPS came in at -$0.03 , while revenue for the quarter reached $2.26M .
Earnings released on 29 Apr 2021
EPS came in at -$0.01 , while revenue for the quarter reached $1.97M .
Earnings released on 30 Nov 2020
EPS came in at -$0.04 , while revenue for the quarter reached $1.45M .
KHRNF Stock Performance
Access detailed KHRNF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.